Media Pack
News

Current Edition

IPI Volume 16 Issue 1
 
 
 
 
 
 
Volume 15 Issue 4

The Trial Master File (TMF)

IPI speaks with Aaron Grant, VP of Solutions Consulting at Phlexglobal, (a PharmaLex Company)on how managing the TMF requires following best practice and taking adva...
19 December 2023 Volume 15 Issue 4 AI | artificial
Continue Reading →
Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...
13 January 2023 Volume 14 Issue 4 application | approval
Continue Reading →
News

Opdivo plus chemo improves event-free survival in NSCLC patients

Bristol Myers Squibb (BMS) has announced that its PD-1 inhibitor Opdivo (nivolumab) plus chemotherapy improved event-free survival in a Phase III trial in patients w...
9 November 2021 News BMS | Bristol Myers Squibb
Continue Reading →
News

AZ announces US fast track designation for IL-5 inhibitor Fasenra

AstraZeneca’s IL-5 inhibitor Fasenra (benralizumab) has received a fast-track designation from the US Food and Drug Administration for the treatment of eosinoph...
9 November 2021 News AstraZeneca | benralizumab
Continue Reading →
News

UK trial to evaluate existing drugs for secondary breast cancer

A new UK-based clinical trial will evaluate existing cancer drugs as potential treatments for women living with metastatic breast cancer. The study, led by Profes...
29 September 2021 News Bavencio | breast cancer
Continue Reading →
News

Promising early results for new ovarian cancer drug combo

Results from an early-stage clinical trial found a new combination of target drugs could provide a new treatment option for treatment-resistant advanced ovarian canc...
22 September 2021 News clinical trial | defactinib
Continue Reading →
News

Enhertu improves progression-free survival in breast cancer trial

Positive topline results from a Phase III trial for Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu have shown that the HER2-directed antibody drug conju...
11 August 2021 News AstraZeneca | breast cancer
Continue Reading →
News

PCI Clinical Services Gets Green Light to Begin Operations in Expansion of European Site

Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has completed validation and received licensing of its newly expanded ...
19 January 2018 News ATMPs | clinical trial
Continue Reading →
News

Plasticell and Anthony Nolan to partner in clinical trials of ex vivo expanded cord blood stem cells

Plasticell, a developer of innovative stem cell technologies and cell therapies, today announced it will collaborate with Anthony Nolan, a leading research organisat...
5 December 2017 News blood | bone marrow
Continue Reading →
News

Sanofi and Principia agree to develop MS drug candidate

Sanofi will develop Principia Biopharma Inc.'s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous syst...
9 November 2017 News autoimmune | central nervous system
Continue Reading →
 
 
 
logo-ipi-w.png

International Pharmaceutical Industry

IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative

Facebook Linkedin Tumblr
IPI Media © 2024, All Rights Reserved – Powered by Teksyte